
Baxter International Inc
Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on our products, and in the communities where our employees live and work. The Foundation helps advance Baxter's Mission to Save and Sustain Lives by partnering with organizations around the world to increase access to healthcare for the underserved, develop the next generation of innovators who will lead the way in advancing healthcare and create a positive, long-lasting impact in communities globally. For more information, please visit Baxter's Corporate Responsibility page. Baxter is a registered trademark of Baxter International Inc. or its subsidiaries. i Carey, Ben, et al., 2022, PLOS One ii Kline et al., 2020, Academic Emergency Medicine SOURCE Pet Partners
Free cash flow has been growing at -21.8% annually.
Current Price
$16.68
-0.60%GoodMoat Value
$50.11
200.4% undervaluedBaxter International Inc (BAX) Financial Statements
GoodMoat Analysis
Baxter International presents a challenging quality profile for a value investor, with significant profitability and leverage concerns offset by a modest free cash flow yield and dividend. The company is currently unprofitable on a GAAP basis with negative margins and returns, while carrying a high debt load.
Read full analysis
BAX Computed Insights
Income Statement
Balance Sheet
Cash Flow Statement
BAX Financial Statements & Data
Baxter International Inc (BAX) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Baxter International Inc's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $11.24B. Gross profit (TTM) is $3.38B. EBITDA is $657.00M. Earnings per share (EPS) is $-1.87. The P/E ratio is -8.96. Market capitalization is $8.57B.
Free cash flow (FCF) is $323.00M. FCF growth rate is -21.76%. EPS growth CAGR is -21.76%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Baxter International Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.